中药注射剂药物代谢动力学研究现状

摘要/Abstract

摘要： 中药注射剂的安全性问题正受到越来越多的关注。药代动力学研究是揭示中药注射剂效应物质基础及其体内过程的重要途径,对于临床合理用药、提高中药注射液质量控制标准与临床用药的有效性、安全性具有十分重要的意义。本文简要分析了中药注射剂药物代谢动力学研究相关进展,指出对中药注射液药代动力学的重视程度尚有待提高。随着近年来中药药代动力学研究技术方法的进步,已逐步具备条件开展中药注射液的体内过程研究,中药注射液的质量控制、安全性评价、工艺优化以及临床合理用药研究等方面应充分利用和结合中药注射液体内过程的研究结果,以保障和提高中药注射液临床用药的有效性与安全性。

关键词: 中药注射剂, 药代动力学, 研究现状

Abstract: The problem of medication safety about herbal injections has gained more and more attention. Pharmacokinetics is not only an important way to reveal the pharmacodynamic material basis and in vivo behavior of herbal injections, but also significant to improve the quality control standards and rational clinical use. This reveal makes a simple introduction about research status of herbal injection pharmacokinetics and indicates that the attention paid to the study is still limited. In recent years, the research of in vivo process about herbal injections could be carried out as the progress of TCM pharmacokinetics. The study of quality control, safety evaluation, process optimization and clinical rational drug use of herbal injections should use the results of the in vivo research to improve and guarantee the efficacy and safety of the injections.

Key words: herbal injection, pharmacokinetics, current advancement

中图分类号:

R969.1

申汉元, 郝海平, 王广基. 中药注射剂药物代谢动力学研究现状[J]. 中国临床药理学与治疗学, 2014, 19(8): 937-942.

SHEN Han-yuan, HAO Hai-ping, WANG Guang-ji. Current advancement on pharmacokinetics study of herbal injection prescription[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 937-942.

参考文献 39

[1]	王瑞芹,冯锐,王欣. 中药注射剂在临床的合理应用[J]. 临床合理用药, 2011, 4(9B): 176-177.
[2]	田原. 我国中药注射制剂发展现状及前景述评[J]. 中国现代中药, 2009, 11(1): 35-38.
[3]	刘昌孝. 中药药代动力学研究的难点和热点[J]. 药学学报, 2005, 40(5): 395-401.
[4]	刘艳. 中药不良反应的诱发因素[J]. 中国医药科学, 2013, 3(16): 138-359.
[5]	张开礼,徐玉红,吴斌,等. 1001份中药注射剂不良反应报告/事件分析[J]. 中国药业, 2013, 22(15): 70-72.
[6]	屈建. 中药注射剂的安全性评价[J]. 中国医院药学杂志, 2009, 29(2): 93-98.
[7]	郝海平,郑超湳,王广基. 多组分、多靶点中药整体药代动力学研究的思考与探索[J]. 药学学报, 2009, 44(3): 270-275.
[8]	Zhang J, Zhou F, Lu M, et al.Pharmacokinetics-pharmacology disconnection of herbal medicines and its potential solutions with cellular pharmacokinetic-pharmacodynamic strategy[J]. Curr Drug Metab, 2012, 13(5):558-576.
[9]	殷锦锦,周本杰. 中药复方药动学的研究进展[J]. 中国药房, 2012, 23(47): 4503-4505.
[10]	Wu LI, Hao H, Wang G.LC/MS Based tools and strategies on qualitative and quantitative analysis of herbal components in complex matrixes[J]. Curr Drug Metab, 2012, 13(9): 1251-1265.
[11]	王志琪,景贤,曾嵘,等. LC-MS/MS测定大鼠血浆中乌头碱的浓度[J]. 中国临床药理学与治疗学, 2012, 17(4): 371-375.
[12]	金晶,赵钟祥,晏菊娇,等. 亚硫酸氢钠穿心莲内酯在Beagle犬体内的药动学研究[J]. 医药导报, 2005, 24(2): 109-111.
[13]	黎国富,赵浩如,杨劲. 中草药新药多成分药代动力学评价的研究进展[J]. 中国中药杂志, 2011, 36(5): 644-649.
[14]	Li X, Sun J, Wang G, et al.Simultaneous determination of panax notoginsenoside R1, ginsenoside Rg1, Rd, Re and Rb1 in rat plasma by HPLC/ESI/MS: platform for the pharmacokinetic evaluation of total panax notoginsenoside, a typical kind of multiple constituent traditional Chinese medicine[J]. Biomed Chromatogr, 2007, 21(7): 735-746.
[15]	Li X, Wang G, Sun J, et al.Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional Chinese medicine (TCM) in rats[J]. Biol Pharm Bull, 2007, 30(5): 847-851.
[16]	李晓宇,郝海平,王广基,等. 三七总皂苷多效应成分整合药代动力学研究[J]. 中国天然药物, 2008, 6(5): 377-381.
[17]	Yu Z, Gao X, Zhao Y, et al.HPLC determination of safflor yellow A and three active isoflavones from TCM Naodesheng in rat plasma and tissues and its application to pharmacokinetic studies[J]. Biomed Chromatogr, 2007, 21(6): 577-584.
[18]	Jia P, Wang S, Meng X, et al.Effects of ionic liquid and nanogold particles on high-performance liquid chromatography-electrochemical detection and their application in highly efficient separation and sensitive analysis of five phenolic acids in Xuebijing injection[J]. Talanta, 2013, 107: 103-110.
[19]	Zheng C, Hao H, Wang X, et al.Diagnostic fragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI- IT-TOF/MS: Shengmai injection as an example[J]. J Mass Spectrom, 2009, 44(2): 230-44.
[20]	Xie T, Liang Y, Hao H, et al.Rapid identification of ophiopogonins and ophiopogonones in Ophiopogon japonicus extract with a practical technique of mass defect filtering based on high resolution mass spectrometry[J]. J Chromatogr A, 2012, 1227: 234-244.
[21]	Wu L, Gong P, Wu Y, et al.An integral strategy toward the rapid identification of analogous nontarget compounds from complex mixtures[J]. J Chromatogr A, 2013, 1303: 39-47.
[22]	Liang Y, Hao H, Kang A, et al.Qualitative and quantitative determination of complicated herbal components by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a relative exposure approach to herbal pharmacokinetics independent of standards[J]. J Chromatogr A, 2010, 1217(30): 4971-4979.
[23]	Wu L, Wu Y, Shen H, et al.Quantitative structure-ion intensity relationship strategy to the prediction of absolute levels without authentic standards[J]. Anal Chim Acta, 2013, 794: 67-75.
[24]	Zhou S1, Koh HL, Gao Y, et al. Edmund Jon Deoon Lee. Herbal bioactivation: The good, the bad and the ugly[J]. Life Sci, 2004, 74(8): 935-968.
[25]	邱峰. 浅谈中药成分体内代谢研究[J]. 国际药学研究杂志, 2010, 37(5): 321-328.
[26]	Liang Y, Hao H, Xie L, et al.Development of a systematic approach to identify metabolites for herbal homologs based on liquid chromatography hybrid ion trap time-of-flight mass spectrometry: gender-related difference in metabolism of schisandra lignans in rats[J]. Drug Metab Dispos, 2010, 38(10): 1747-1759.
[27]	Gong P, Cui N, Wu L, et al.Chemicalome and metabolome matching approach to elucidating biological metabolic networks of complex mixtures[J]. Anal Chem, 2012, 84(6): 2995-3002.
[28]	Izzo A A.Interactions between herbs and conventional drugs: overview of the clinical data[J]. Med Princ Pract, 2012, 21(5): 404-28.
[29]	Bush TM, Rayburn KS, Holloway SW, et al.Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey[J]. Altern Ther Health Med, 2007, 13(2): 30-35.
[30]	Wu JJ, Ai CZ, Liu Y, et al.Interactions between phytochemicals from traditional Chinese medicines and human cytochrome P450 enzymes[J]. Curr Drug Metab, 2012, 13(5): 599-614.
[31]	Li L, Hu H, Xu S, et al.Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions[J]. Curr Drug Metab, 2012, 13(5): 615-623.
[32]	Liang Y, Zhou Y, Zhang J, et al.In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein[J]. Phytomedicine, 2013, 20(11): 1030-1038.
[33]	Jaldappagari S, Balakrishnan S, Hegde AH, et al.Interactions of polyphenols with plasma proteins: insightsfrom analytical techniques[J]. Curr Drug Metab, 2013, 14(4): 456-473.
[34]	Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions[J]. Planta Med, 2012, 78(13): 1458-1477.
[35]	Chen XW, Serag ES, Sneed KB, et al.Clinical herbal interactions with conventional drugs: from molecules to maladies[J]. Curr Med Chem, 2011, 18(31): 4836-4850.
[36]	Hao H, Zheng X, Li P, et al.Translational Research Insights into Pharmacokinetic Herb-Drug Interactions[J]. Curr Drug Metab, 2011, 12(9): 850-870.
[37]	李晗,王宇光,马增春,等. 基于临床用量的参附注射液对大鼠肝脏主要药物代谢酶的影响[J]. 药学学报, 2013, 48(5): 728-733.
[38]	赵文婷,张波,李湘晖,等. 疏血通注射液对大鼠细胞色素P450酶6种亚型活性的影响[J]. 中国新药与临床药理, 2012, 23(4): 445-449.
[39]	吴淳,高静雯,姚美村,等. 天然冰片对大鼠细胞色素P450四种亚型活性的影响[J]. 中国临床药理学与治疗学, 2013, 18(2): 121-127.